AHR and breast carcinoma: Knockdown of Ahr abrogated the inhibitory effects of TCDD (10 nmol/L) and DIM (25 μmol/L) on invasion of MDA-MB-231 and T47D cells (Fig. 1e), showing that Ahr mediated the agonists-suppressed invasion of breast cancer cells.